IGC Pharma (IGC) Depreciation & Amortization - Total (2010 - 2014)
IGC Pharma (IGC) reported Depreciation & Amortization - Total of $148889.0 for Q2 2014, little changed year-over-year from $149294.0 in Q2 2013, and down 44.33% quarter-over-quarter from $267462.0 in Q1 2014.
IGC Pharma (IGC) Depreciation & Amortization - Total (2010 - 2014) Analysis & Trends
IGC Pharma (IGC) has 5 years of Depreciation & Amortization - Total data on file, last reported at $148889.0 in Q2 2014.
- Depreciation & Amortization - Total for Q2 2014 came in at $148889.0, changed 0.27% year-over-year; the trailing twelve-month figure through Mar 2015 was $148889.0 (down 79.1% YoY), and the FY2014 annual result was $712314.0, up 5.7% from the prior year.
- Depreciation & Amortization - Total slipped to $148889.0 in Q2 2014 per IGC's latest filing, from $267462.0 in the prior quarter.
- Over five years, Depreciation & Amortization - Total peaked at $827178.0 in Q1 2012 and troughed at $42360.0 in Q4 2011.
- A 5-year average of $230843.9 and a median of $147850.0 in 2013 frame the typical range for Depreciation & Amortization - Total.
- The sharpest annual moves came in 2011 and 2012: Depreciation & Amortization - Total sank 90.82% in 2011, then surged 224.15% in 2012.
- A 5-year view of Depreciation & Amortization - Total shows it stood at $461627.0 in 2010, then tumbled by 90.82% to $42360.0 in 2011, then soared by 218.19% to $134785.0 in 2012, then grew by 9.59% to $147708.0 in 2013, then rose by 0.8% to $148889.0 in 2014.
- Business Quant data shows IGC's Depreciation & Amortization - Total at $148889.0 in Q2 2014, $267462.0 in Q1 2014, and $147708.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 148,889.00 |
| Mar 31, 2014 | 267,462.00 |
| Dec 31, 2013 | 147,708.00 |
| Sep 30, 2013 | 147,850.00 |
| Jun 30, 2013 | 149,294.00 |
| Mar 31, 2013 | 210,413.00 |
| Dec 31, 2012 | 134,785.00 |
| Sep 30, 2012 | 245,125.00 |
| Jun 30, 2012 | 83,594.00 |
| Mar 31, 2012 | 827,178.00 |
| Dec 31, 2011 | 42,360.00 |
| Sep 30, 2011 | 75,621.00 |
| Jun 30, 2011 | 51,244.00 |
| Mar 31, 2011 | 733,822.00 |
| Dec 31, 2010 | 461,627.00 |
| Sep 30, 2010 | 100,930.00 |
| Jun 30, 2010 | 96,444.00 |